Molecular changes associated with vascular malformations

Arash Fereydooni1, Alan Dardik2, Naiem Nassiri2

  • 1Yale University School of Medicine, New Haven, Conn.

Insights

Genetic mutations in vascular malformations are linked to specific signaling pathways. Targeting these pathways offers new therapeutic strategies for vascular anomalies.

Area of Science:

  • Vascular biology and genetics
  • Molecular mechanisms of disease
  • Medical and surgical treatment of vascular anomalies

Background:

  • Vascular anomalies are broadly categorized into tumors and malformations.
  • Somatic mosaic gene mutations are the primary cause of most vascular malformations.
  • Genetic research has elucidated key biomolecular pathways in pathogenesis.

Purpose of the Study:

  • To review the updated International Society for Study of Vascular Anomalies classification.
  • To highlight potential therapeutic targets based on genetic findings.
  • To provide vascular surgeons with an updated perspective on etiologies.

Main Methods:

  • Literature review of current research on vascular anomalies.
  • Analysis of genetic mutations and associated signaling pathways.
  • Integration of updated classification systems.

Main Results:

  • Vascular malformations are linked to specific genetic mutations.
  • RAS/MAPK/ERK pathway mutations are associated with fast-flow arteriovenous malformations.
  • PI3K/AKT/mTOR pathway mutations are associated with slow-flow venous and lymphatic malformations.

Conclusions:

  • Understanding the genetic basis of vascular malformations informs targeted therapies.
  • Therapeutic strategies should focus on the specific mutated etiological pathways.
  • This knowledge facilitates multidisciplinary collaboration for improved patient care.